Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN).
Bar J, Peled N, Schokrpur S, Wolner M, Rotem O, Girard N, Aboubakar Nana F, Derijcke S, Kian W, Patel S, Gantz-Sorotsky H, Zer A, Moskovitz M, Metro G, Rottenberg Y, Calles A, Hochmair M, Cuppens K, Decoster L, Reck M, Limon D, Rodriguez E, Astaras C, Bettini A, Häfliger S, Addeo A. Bar J, et al. Among authors: rottenberg y. J Thorac Oncol. 2023 Feb;18(2):169-180. doi: 10.1016/j.jtho.2022.10.004. Epub 2022 Oct 25. J Thorac Oncol. 2023. PMID: 36307041 Free article.
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
Dudnik E, Moskovitz M, Rottenberg Y, Lobachov A, Mandelboim R, Shochat T, Urban D, Wollner M, Nechushtan H, Rotem O, Zer A, Daher S, Bar J; Israel Lung Cancer Group. Dudnik E, et al. Among authors: rottenberg y. Oncoimmunology. 2021 Jan 28;10(1):1865653. doi: 10.1080/2162402X.2020.1865653. Oncoimmunology. 2021. PMID: 33552685 Free PMC article.
dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50.
Holtzman L, Moskovitz M, Urban D, Nechushtan H, Keren S, Reinhorn D, Wollner M, Daher S, Rottenberg Y, Rovitzky Y, Shochat T, Bar J, Dudnik E. Holtzman L, et al. Among authors: rottenberg y. Clin Lung Cancer. 2022 Mar;23(2):122-134. doi: 10.1016/j.cllc.2021.12.006. Epub 2021 Dec 24. Clin Lung Cancer. 2022. PMID: 35034862
Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing.
Sehayek O, Kian W, Onn A, Stoff R, Sorotsky HG, Zemel M, Bar J, Dudnik Y, Nechushtan H, Rottenberg Y, Soussan-Gutman L, Dvir A, Roisman LC, Peled N. Sehayek O, et al. Among authors: rottenberg y. Front Oncol. 2022 Jun 15;12:912801. doi: 10.3389/fonc.2022.912801. eCollection 2022. Front Oncol. 2022. PMID: 35785173 Free PMC article.
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.
Daher S, Zer A, Tschernichovsky R, Yacobi R, Barshack I, Tsabari S, Rottenberg Y, Zick A, Gottfried T, Lobachov A, Marom EM, Urban D, Saad A, Gantz-Sorotsky H, Onn A, Bar J. Daher S, et al. Among authors: rottenberg y. Lung Cancer. 2023 Apr;178:229-236. doi: 10.1016/j.lungcan.2023.02.023. Epub 2023 Mar 2. Lung Cancer. 2023. PMID: 36898331 Free article.
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy.
Tsur E, Blumenfeld P, Rottenberg Y, Nechushtan H, Arnon J, Wald O, Izhar U, Pfeffer R, Krakow A, Wygoda M, Popovtzer A, Michaeli TF. Tsur E, et al. Among authors: rottenberg y. Transl Lung Cancer Res. 2024 Mar 29;13(3):465-474. doi: 10.21037/tlcr-23-802. Epub 2024 Mar 22. Transl Lung Cancer Res. 2024. PMID: 38601442 Free PMC article.
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.
Golan S, Bar V, Salpeter SJ, Neev G, Creiderman G, Kedar D, Aharon S, Turovsky L, Zundelevich A, Shahar H, Shapira H, Mallel G, Stossel E, Gavert N, Straussman R, Dotan Z, Berger R, Stossel C, Golan T, Halperin S, Leibovici D, Breuer S, Rottenberg Y, Applebaum L, Hubert A, Nechushtan H, Peretz T, Zick A, Chertin B, Koulikov D, Sonnenblick A, Rosenbaum E. Golan S, et al. Among authors: rottenberg y. Front Med (Lausanne). 2023 Sep 28;10:1221484. doi: 10.3389/fmed.2023.1221484. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37840996 Free PMC article.
65 results